Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
1906 | 5908 | 35.8 | 66% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
111 | 3 | THROMBOSIS RESEARCH//THROMBOSIS AND HAEMOSTASIS//HEMATOLOGY | 71244 |
1906 | 2 | ALPHA 1 ANTITRYPSIN DEFICIENCY//ALPHA 1 ANTITRYPSIN//ALPHA1 ANTITRYPSIN DEFICIENCY | 5908 |
1007 | 1 | ALPHA 1 ANTITRYPSIN DEFICIENCY//ALPHA 1 ANTITRYPSIN//ALPHA1 ANTITRYPSIN DEFICIENCY | 2906 |
7218 | 1 | ELAFIN//SLPI//SECRETORY LEUKOCYTE PROTEASE INHIBITOR | 1391 |
13510 | 1 | ELASTASE INHIBITOR//PROTEINASE K INHIBITOR//HUMAN LEUKOCYTE ELASTASE | 832 |
23573 | 1 | CAP37//CATIONIC ANTIMICROBIAL PROTEIN//AZUROPHIL GRANULE | 341 |
24005 | 1 | NEUTROPHIL ELASTASE INHIBITOR//SIVELESTAT//NEUTROPHIL ELASTASE | 326 |
34382 | 1 | TETRANECTIN//COILED COIL DOMAIN CONTAINING 3 GENE//FAVINE GENE | 112 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ALPHA 1 ANTITRYPSIN DEFICIENCY | authKW | 643467 | 3% | 69% | 181 |
2 | ALPHA 1 ANTITRYPSIN | authKW | 596775 | 4% | 45% | 258 |
3 | ALPHA1 ANTITRYPSIN DEFICIENCY | authKW | 379112 | 2% | 69% | 107 |
4 | ALPHA1 ANTITRYPSIN | authKW | 331524 | 2% | 45% | 144 |
5 | ELAFIN | authKW | 279493 | 1% | 78% | 69 |
6 | SERPIN | authKW | 262884 | 4% | 23% | 220 |
7 | SLPI | authKW | 225089 | 1% | 68% | 64 |
8 | SECRETORY LEUKOCYTE PROTEASE INHIBITOR | authKW | 181891 | 1% | 70% | 50 |
9 | NEUTROPHIL ELASTASE | authKW | 164826 | 2% | 27% | 118 |
10 | ANTITRYPSIN | authKW | 123973 | 1% | 67% | 36 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Respiratory System | 19667 | 15% | 0% | 910 |
2 | Biochemistry & Molecular Biology | 6079 | 29% | 0% | 1733 |
3 | Medicine, Research & Experimental | 1517 | 7% | 0% | 419 |
4 | Critical Care Medicine | 1406 | 3% | 0% | 198 |
5 | Biophysics | 1114 | 6% | 0% | 357 |
6 | Chemistry, Medicinal | 1073 | 5% | 0% | 280 |
7 | Cell Biology | 926 | 8% | 0% | 497 |
8 | Medical Laboratory Technology | 718 | 2% | 0% | 123 |
9 | Pathology | 671 | 4% | 0% | 219 |
10 | Genetics & Heredity | 581 | 6% | 0% | 329 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | LUNG INVEST UNIT | 38246 | 0% | 37% | 20 |
2 | LUNG FUNCT SLEEP | 31248 | 0% | 55% | 11 |
3 | PROT STRAIN | 25833 | 0% | 100% | 5 |
4 | AD T PROJECT | 23010 | 0% | 64% | 7 |
5 | BIODEF MED | 22452 | 0% | 43% | 10 |
6 | CAMBRIDGE MED | 22193 | 2% | 5% | 95 |
7 | EVALUAT RISKS HUMAN REPROD | 21526 | 0% | 83% | 5 |
8 | BIOCHIM BIOL MOL HMNO | 15500 | 0% | 100% | 3 |
9 | DIAG INHERITED ANTITRYPSIN DEFICIENCY ALPHA1 | 15500 | 0% | 100% | 3 |
10 | PEDIATUPMC NEWBORN MED PROGRAM | 15500 | 0% | 100% | 3 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | AMERICAN REVIEW OF RESPIRATORY DISEASE | 23447 | 3% | 3% | 168 |
2 | COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 11357 | 1% | 6% | 37 |
3 | BIOLOGICAL CHEMISTRY HOPPE-SEYLER | 11308 | 1% | 4% | 58 |
4 | CLINICAL RESPIRATORY PHYSIOLOGY-BULLETIN EUROPEEN DE PHYSIOPATHOLOGIE RESPIRATOIRE | 6343 | 0% | 9% | 14 |
5 | HUMAN HEREDITY | 5696 | 1% | 2% | 48 |
6 | AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY | 4471 | 1% | 1% | 67 |
7 | EXPERIMENTAL LUNG RESEARCH | 2940 | 1% | 2% | 32 |
8 | EUROPEAN RESPIRATORY JOURNAL | 2297 | 1% | 1% | 65 |
9 | EUROPEAN JOURNAL OF RESPIRATORY DISEASES | 2220 | 0% | 2% | 25 |
10 | HOPPE-SEYLERS ZEITSCHRIFT FUR PHYSIOLOGISCHE CHEMIE | 2063 | 0% | 2% | 18 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ALPHA 1 ANTITRYPSIN DEFICIENCY | 643467 | 3% | 69% | 181 | Search ALPHA+1+ANTITRYPSIN+DEFICIENCY | Search ALPHA+1+ANTITRYPSIN+DEFICIENCY |
2 | ALPHA 1 ANTITRYPSIN | 596775 | 4% | 45% | 258 | Search ALPHA+1+ANTITRYPSIN | Search ALPHA+1+ANTITRYPSIN |
3 | ALPHA1 ANTITRYPSIN DEFICIENCY | 379112 | 2% | 69% | 107 | Search ALPHA1+ANTITRYPSIN+DEFICIENCY | Search ALPHA1+ANTITRYPSIN+DEFICIENCY |
4 | ALPHA1 ANTITRYPSIN | 331524 | 2% | 45% | 144 | Search ALPHA1+ANTITRYPSIN | Search ALPHA1+ANTITRYPSIN |
5 | ELAFIN | 279493 | 1% | 78% | 69 | Search ELAFIN | Search ELAFIN |
6 | SERPIN | 262884 | 4% | 23% | 220 | Search SERPIN | Search SERPIN |
7 | SLPI | 225089 | 1% | 68% | 64 | Search SLPI | Search SLPI |
8 | SECRETORY LEUKOCYTE PROTEASE INHIBITOR | 181891 | 1% | 70% | 50 | Search SECRETORY+LEUKOCYTE+PROTEASE+INHIBITOR | Search SECRETORY+LEUKOCYTE+PROTEASE+INHIBITOR |
9 | NEUTROPHIL ELASTASE | 164826 | 2% | 27% | 118 | Search NEUTROPHIL+ELASTASE | Search NEUTROPHIL+ELASTASE |
10 | ANTITRYPSIN | 123973 | 1% | 67% | 36 | Search ANTITRYPSIN | Search ANTITRYPSIN |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SANTANGELO, S , SCARLATA, S , POETA, ML , BIALAS, AJ , PAONE, G , INCALZI, RA , (2017) ALPHA-1 ANTITRYPSIN DEFICIENCY: CURRENT PERSPECTIVE FROM GENETICS TO DIAGNOSIS AND THERAPEUTIC APPROACHES.CURRENT MEDICINAL CHEMISTRY. VOL. 24. ISSUE 1. P. 65 -90 | 152 | 81% | 0 |
2 | STOLLER, JK , ABOUSSOUAN, LS , (2012) A REVIEW OF ALPHA(1)-ANTITRYPSIN DEFICIENCY.AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. VOL. 185. ISSUE 3. P. 246 -259 | 116 | 81% | 83 |
3 | HENAO, MP , CRAIG, TJ , (2016) RECENT ADVANCES IN UNDERSTANDING AND TREATING COPD RELATED TO (1)-ANTITRYPSIN DEFICIENCY.EXPERT REVIEW OF RESPIRATORY MEDICINE. VOL. 10. ISSUE 12. P. 1281 -1294 | 119 | 88% | 0 |
4 | GREENE, CM , MARCINIAK, SJ , TECKMAN, J , FERRAROTTI, I , BRANTLY, ML , LOMAS, DA , STOLLER, JK , MCELVANEY, NG , (2016) ALPHA 1-ANTITRYPSIN DEFICIENCY.NATURE REVIEWS DISEASE PRIMERS. VOL. 2. ISSUE . P. - | 127 | 76% | 0 |
5 | GOOPTU, B , LOMAS, DA , (2009) CONFORMATIONAL PATHOLOGY OF THE SERPINS: THEMES, VARIATIONS, AND THERAPEUTIC STRATEGIES.ANNUAL REVIEW OF BIOCHEMISTRY. VOL. 78. ISSUE . P. 147-176 | 111 | 78% | 99 |
6 | SALAHUDDIN, P , (2010) GENETIC VARIANTS OF ALPHA(1)-ANTITRYPSIN.CURRENT PROTEIN & PEPTIDE SCIENCE. VOL. 11. ISSUE 2. P. 101-117 | 119 | 85% | 13 |
7 | DICKENS, JA , LOMAS, DA , (2011) WHY HAS IT BEEN SO DIFFICULT TO PROVE THE EFFICACY OF ALPHA-1-ANTITRYPSIN REPLACEMENT THERAPY? INSIGHTS FROM THE STUDY OF DISEASE PATHOGENESIS.DRUG DESIGN DEVELOPMENT AND THERAPY. VOL. 5. ISSUE . P. 391 -405 | 104 | 92% | 18 |
8 | GOOPTU, B , DICKENS, JA , LOMAS, DA , (2014) THE MOLECULAR AND CELLULAR PATHOLOGY OF ALPHA(1)-ANTITRYPSIN DEFICIENCY.TRENDS IN MOLECULAR MEDICINE. VOL. 20. ISSUE 2. P. 116 -127 | 95 | 86% | 17 |
9 | EKEOWA, UI , GOOPTU, B , BELORGEY, D , HAGGLOF, P , KARLSSON-LI, S , MIRANDA, E , PEREZ, J , MACLEOD, I , KROGER, H , MARCINIAK, SJ , ET AL (2009) ALPHA(1)-ANTITRYPSIN DEFICIENCY, CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND THE SERPINOPATHIES.CLINICAL SCIENCE. VOL. 116. ISSUE 11-12. P. 837-850 | 122 | 78% | 30 |
10 | MOREAU, T , BARANGER, K , DADE, S , DALLET-CHOISY, S , GUYOTL, N , ZANI, ML , (2008) MULTIFACETED ROLES OF HUMAN ELAFIN AND SECRETORY LEUKOCYTE PROTEINASE INHIBITOR (SLPI), TWO SERINE PROTEASE INHIBITORS OF THE CHELONIANIN FAMILY.BIOCHIMIE. VOL. 90. ISSUE 2. P. 284 -295 | 103 | 82% | 88 |
Classes with closest relation at Level 2 |